Biotech tropicana.IncLIFE STORES: A Tentative Product Description Outline. Version 1.

PRODUCTS OF THE BIOTECH TROPICANA SYSTEMS

--------------

Aboubakr YARI1: Venus YARI1: And Myra YARI2

--------------

Affiliations:

Biotech tropicana Systems

Marketing Body, Biotech tropicana Corporation

--------------------------------------------------------

Abstract:

The Biotech tropicana Systems innovate, develop, and commercialize biotechnology products in the areas of HEALTH, FOOD, ENERGY, and ENVIRONMENT. Here, we discuss a tentative description of a health product made in the Biotech tropicana Systems.

Keywords: Biotechnology Products: Made In The Biotech tropicana Systems: Health: Resource Poor Settings:

Description:

Product Name: SMARThivPACK

Trade Name: The Life Box

Background:

CD4 MANUAL

WHO/UNAIDS

Manual methods

Currently available manual assays rely on microscopes (optical or fluorescence). Additionally, they require the use of other small equipment such as centrifuges and magnets.

These tests are designed to operate with low sample throughput in resource-limited laboratories but their running costs are not always lower when compared to the automated methods. Performance details of two tests that are presently available in the market are shown in Table 2. These are the Cyto-Spheres (Coulter Corporation, USA) and the Dynabeads (Dynal AS, Norway). Other alternative methods such as Capcellia (Bio-Rad, USA), OPTI-CIM (CIMA, Cuba), TRAxELISA (Innogenetics, Belgium), Zymmune (Zynaxis Inc., USA) and the immunoalkaline assay are no longer available in the market and/or are considered to be obsolete.

------------------

Capcellia (Bio-Rad, USA) version 2. (version 1, See Sanofi Pasteur, France)

TRAxELISA (Innogenetics, Belgium)

NOTE:

No longer available in the market and/or are considered to be obsolete.

Reference:

WHO/UNAIDS: CD4+ T- CELL ENUMERATION

TECHNOLOGIES. TECHNICAL INFORMATION

Dynabeads (Dynal AS, Norway) version 1.

Modified by Oka S et al; International Medical Center of Japan. Version 2.

In summary, the various technologies currently available for enumerating CD4+ T-cells are based on distinct principles and have different operational characteristics. The selection of the appropriate technology for a given laboratory should be guided by factors such as

the purpose of the assay (routine vs. research),

age group of the patients (pediatrics require CD4 percentage),

sample turnover and

available resources (financial, human and infrastructure).

Financial (COST)

human and infrastructure (COMPLEXITY)

NOTES:

Cost and complexity are the major challenges to the developing world to keeping pace with international standards.

Solutions:

SMARThivPACK: Yari et al;

Cost and complexity engineering to improve standard in the resource poor settings.

SMARThivPACK designed in compliance with international standards. Same standard for rich and poor patients in the context of the same disease.

Before SMARThivPACK:

3 tests for rich patients. 1 test for poor patients. Both rich and poor suffer from the same disease.

ISSUE: Ethics.

After SMARThivPACK:

3 test for rich patients. 3 tests for poor patients.

Same disease, same treatment.

Ethical concerns resolved.

The Life Stores ID #:

Made In The Biotech tropicana Systems

Biotech tropicana Systems:

Small techs, Big Solutions.

For the Developing World.

Biotech tropicana Systems:

World Leader In Biotechnology For The Developing World.

-----------------------------------------------------------------------------------------------------------------------------

Aboubakar YARI & Venus YARI, Owners

Myra YARI, Marketing Coordinator

Biotech tropicana Systems:

Reference:

 [1]  Yari et al: SMARThivPACK at pubmed.gov; keyword: smarthivpack.